-
1
-
-
41349099104
-
Cancer statistics, 2008
-
Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58:71-96.
-
(2008)
CA Cancer J Clin
, vol.58
, pp. 71-96
-
-
Jemal, A.1
Siegel, R.2
Ward, E.3
-
2
-
-
42249094731
-
Pharmaceutical management of ovarian cancer: Current status
-
Markman M. Pharmaceutical management of ovarian cancer: current status. Drugs. 2008;68:771-789.
-
(2008)
Drugs
, vol.68
, pp. 771-789
-
-
Markman, M.1
-
3
-
-
40849139532
-
Second-line randomized trials in epithelial ovarian cancer
-
suppl 1)
-
Vermorken JB. Second-line randomized trials in epithelial ovarian cancer. Int J Gynecol Cancer. 2008;18(suppl 1):59-66.
-
(2008)
Int J Gynecol Cancer
, vol.18
, pp. 59-66
-
-
Vermorken, J.B.1
-
4
-
-
0021908232
-
Subunit M2 of mammalian ribonucleotide reductase. Characterization of a homogeneous protein isolated from M2-overproducing mouse cells
-
Thelander M, Graslund A, Thelander L. Subunit M2 of mammalian ribonucleotide reductase. Characterization of a homogeneous protein isolated from M2-overproducing mouse cells. J Biol Chem. 1985;260:2737-2741.
-
(1985)
J Biol Chem
, vol.260
, pp. 2737-2741
-
-
Thelander, M.1
Graslund, A.2
Thelander, L.3
-
6
-
-
0019819578
-
Ribonucleotide reductase incultured mouse lymphoma cells. Cell cycle-dependent variation in the activity of subunit protein M2
-
Eriksson S, Martin DW Jr. Ribonucleotide reductase incultured mouse lymphoma cells. Cell cycle-dependent variation in the activity of subunit protein M2. J Biol Chem. 1981;256:9436-9440.
-
(1981)
J Biol Chem
, vol.256
, pp. 9436-9440
-
-
Eriksson, S.1
Martin Jr., D.W.2
-
7
-
-
60249091269
-
Regulation of p53 R2 and its role as potential target for cancer therapy
-
Wang X, Zhenchuk A, Wiman KG, et al. Regulation of p53 R2 and its role as potential target for cancer therapy. Cancer Lett. 2009;276:1-7.
-
(2009)
Cancer Lett
, vol.276
, pp. 1-7
-
-
Wang, X.1
Zhenchuk, A.2
Wiman, K.G.3
-
8
-
-
0022260274
-
Cell cycle-dependent expression of mammalian ribonucleotide reductase. Differential regulation of the two subunits
-
Engström Y, Eriksson S, Jildevik I, et al. Cell cycle-dependent expression of mammalian ribonucleotide reductase. Differential regulation of the two subunits. J Biol Chem. 1985;260:9114-9116.
-
(1985)
J Biol Chem
, vol.260
, pp. 9114-9116
-
-
Engström, Y.1
Eriksson, S.2
Jildevik, I.3
-
9
-
-
70149119002
-
Clinical pharmacology and pharmacogenetics of gemcitabine
-
Wong A, Soo RA, Yong WP, et al. Clinical pharmacology and pharmacogenetics of gemcitabine. Drug Metab Rev. 2009;41:77-88.
-
(2009)
Drug Metab Rev
, vol.41
, pp. 77-88
-
-
Wong, A.1
Soo, R.A.2
Yong, W.P.3
-
10
-
-
1542742114
-
RNA interference targeting the M2 subunit of ribonucleotide reductase enhances pancreatic adenocarcinoma chemosensitivity to gemcitabine
-
Duxbury MS, Ito H, Zinner MJ, et al. RNA interference targeting the M2 subunit of ribonucleotide reductase enhances pancreatic adenocarcinoma chemosensitivity to gemcitabine. Oncogene. 2004;23:1539-1548.
-
(2004)
Oncogene
, vol.23
, pp. 1539-1548
-
-
Duxbury, M.S.1
Ito, H.2
Zinner, M.J.3
-
11
-
-
34447503264
-
Ribonucleotide reductase subunit M2 mRNA expression in pretreatment biopsies obtained from unresectable pancreatic carcinomas
-
Itoi T, Sofuni A, Fukushima N, et al. Ribonucleotide reductase subunit M2 mRNA expression in pretreatment biopsies obtained from unresectable pancreatic carcinomas. J Gastroenterol. 2007;42:389-394.
-
(2007)
J Gastroenterol
, vol.42
, pp. 389-394
-
-
Itoi, T.1
Sofuni, A.2
Fukushima, N.3
-
12
-
-
33846296549
-
RRM2 induces NF-kappaB-dependent MM P-9 activation and enhances cellular invasivenenss
-
Duxbury MS, Whang EE. RRM2 induces NF-kappaB-dependent MM P-9 activation and enhances cellular invasivenenss. Biochem Biophys Res Commun. 2007;354:190-196.
-
(2007)
Biochem Biophys Res Commun
, vol.354
, pp. 190-196
-
-
Duxbury, M.S.1
Whang, E.E.2
-
13
-
-
33847417505
-
Ribonucleotide reductase subunits M2 and p53R2 are potential biomarkers for metastasis of colon cancer
-
Liu X, Zhou B, Xue L, et al. Ribonucleotide reductase subunits M2 and p53R2 are potential biomarkers for metastasis of colon cancer. Clin Colorectal Cancer. 2007;6:374-381.
-
(2007)
Clin Colorectal Cancer
, vol.6
, pp. 374-381
-
-
Liu, X.1
Zhou, B.2
Xue, L.3
-
14
-
-
63849188689
-
Overexpression of RRM2 decreases thrombspondin-1 and increases VEGF production in human cancer cells in vitro and in vivo: Implication of RRM2 in angiogenesis
-
Zhang K, Hu S, Wu J, et al. Overexpression of RRM2 decreases thrombspondin-1 and increases VEGF production in human cancer cells in vitro and in vivo: implication of RRM2 in angiogenesis. Mol Cancer. 2009;8:11.
-
(2009)
Mol Cancer
, vol.8
, pp. 11
-
-
Zhang, K.1
Hu, S.2
Wu, J.3
-
15
-
-
43649096317
-
Ribonucleotide reductase subunits M1 and M2 mRNA expression levels and clinical outcome of lung adenocarcinoma patients treated with docetaxel/gemcitabine
-
Souglakos J, Boukovinas I, Taron M, et al. Ribonucleotide reductase subunits M1 and M2 mRNA expression levels and clinical outcome of lung adenocarcinoma patients treated with docetaxel/gemcitabine. Br J Cancer. 2008;98:1710-1715.
-
(2008)
Br J Cancer
, vol.98
, pp. 1710-1715
-
-
Souglakos, J.1
Boukovinas, I.2
Taron, M.3
-
16
-
-
0032522647
-
The mammalian ribonucleotide reductase R2 component cooperates with a variety of oncogenes in mechanisms of cellular transformation
-
Fan H, Villegas C, Huang A, et al. The mammalian ribonucleotide reductase R2 component cooperates with a variety of oncogenes in mechanisms of cellular transformation. Cancer Res. 1998;58:1650-1653.
-
(1998)
Cancer Res
, vol.58
, pp. 1650-1653
-
-
Fan, H.1
Villegas, C.2
Huang, A.3
-
17
-
-
0030450403
-
Ribonucleotide reductase R2 component is a novel malignancy determinant that cooperates with activated oncogenes to determine transformation and malignant potential
-
Fan H, Villegas C, Wright JA. Ribonucleotide reductase R2 component is a novel malignancy determinant that cooperates with activated oncogenes to determine transformation and malignant potential. Proc Natl Acad Sci USA. 1996;93:14036-14040.
-
(1996)
Proc Natl Acad Sci USA
, vol.93
, pp. 14036-14040
-
-
Fan, H.1
Villegas, C.2
Wright, J.A.3
-
18
-
-
0042173218
-
SiRNA-mediated inhibition of vascular endothelial growth factor severely limits tumor resistance to antiangiogenic thrombospondin-1 and slows tumor vascularization and growth
-
Filleur S, Courtin A, Ait-Si-Ali S, et al. SiRNA-mediated inhibition of vascular endothelial growth factor severely limits tumor resistance to antiangiogenic thrombospondin-1 and slows tumor vascularization and growth. Cancer Res. 2003;63:3919-3922.
-
(2003)
Cancer Res
, vol.63
, pp. 3919-3922
-
-
Filleur, S.1
Courtin, A.2
Ait-Si-Ali, S.3
-
19
-
-
0038756442
-
Use of RNA interference to target cyclin E-overexpressing hepatocellular carcinoma
-
Li K, Lin SY, Brunicardi FC, et al. Use of RNA interference to target cyclin E-overexpressing hepatocellular carcinoma. Cancer Res. 2003;63:3593-3597.
-
(2003)
Cancer Res
, vol.63
, pp. 3593-3597
-
-
Li, K.1
Lin, S.Y.2
Brunicardi, F.C.3
-
20
-
-
0037526598
-
Modulation of the classical multidrug resistance (MDR) phenotype by RNA interference (RNAi)
-
Nieth C, Priebsch A, Stege A, et al. Modulation of the classical multidrug resistance (MDR) phenotype by RNA interference (RNAi). FEBS Lett. 2003;545:144-150.
-
(2003)
FEBS Lett
, vol.545
, pp. 144-150
-
-
Nieth, C.1
Priebsch, A.2
Stege, A.3
-
21
-
-
3843087480
-
Retrovirally mediated RNA interference targeting the M2 subunit of ribonucleotide reductase: A novel therapeutic strategy in pancreatic cancer
-
Duxbury MS, Ito H, Benoit E, et al. Retrovirally mediated RNA interference targeting the M2 subunit of ribonucleotide reductase: a novel therapeutic strategy in pancreatic cancer. Surgery. 2004;136:261-269.
-
(2004)
Surgery
, vol.136
, pp. 261-269
-
-
Duxbury, M.S.1
Ito, H.2
Benoit, E.3
-
22
-
-
19044394312
-
Overview of ribonucleotide reductase inhibitors: An appealing target in anti-tumour therapy
-
Cerqueira NM, Pereira S, Fernandes PA, et al. Overview of ribonucleotide reductase inhibitors: an appealing target in anti-tumour therapy. Curr Med Chem. 2005;12:1283-1294.
-
(2005)
Curr Med Chem
, vol.12
, pp. 1283-1294
-
-
Cerqueira, N.M.1
Pereira, S.2
Fernandes, P.A.3
-
23
-
-
84872031610
-
Overexpression of catalytic subunit M2 in patients with ovarian cancer
-
Wang LM, Lu FF, Zhang SY, et al. Overexpression of catalytic subunit M2 in patients with ovarian cancer. Chin Med J (Engl). 2012;125:2151-2156.
-
(2012)
Chin Med J (Engl)
, vol.125
, pp. 2151-2156
-
-
Wang, L.M.1
Lu, F.F.2
Zhang, S.Y.3
-
24
-
-
0009633094
-
Molecular mechanism of transcriptional activation of human gelatinase B by proximal promoter
-
He C. Molecular mechanism of transcriptional activation of human gelatinase B by proximal promoter. Cancer Lett. 1996;106:185-191.
-
(1996)
Cancer Lett
, vol.106
, pp. 185-191
-
-
He, C.1
-
25
-
-
0035735691
-
Human ribonucleotide reductase M2 subunit gene amplification and transcriptional regulation in a homogeneous staining chromosome region responsible for the mechanism of drug resistance
-
Zhou B, Mo X, Liu X, et al. Human ribonucleotide reductase M2 subunit gene amplification and transcriptional regulation in a homogeneous staining chromosome region responsible for the mechanism of drug resistance. Cytogenet Cell Genet. 2001;95:34-42. Science & Technology Commission
-
(2001)
Cytogenet Cell Genet
, vol.95
, pp. 34-42
-
-
Zhou, B.1
Mo, X.2
Liu, X.3
|